Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Fuhr

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Biochemical Pharmacology|July 12, 2002
Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2Andreas Labedzki, Jeroen Buters, Wafaâ Jabrane, et al.
Rapid Communications in Mass Spectrometry : RCM|July 30, 2004
Quantification of mephenytoin and its metabolites 4'-hydroxymephenytoin and nirvanol in human urine using a simple sample processing methodTobias Klaassen, Dirk Kasel, Stefanie Harlfinger, et al.
Clinical Pharmacokinetics|August 14, 2008
Pharmacogenetics of oral anticoagulants: a basis for dose individualizationSimone Stehle, Julia Kirchheiner, Andreas Lazar, et al.
Toxicology Mechanisms and Methods|December 22, 2012
The role of human cytochrome P450 enzymes in metabolism of acrylamide in vitroDaria Kraus, Dennis Rokitta, Uwe Fuhr, et al.
Clinical Pharmacokinetics|June 22, 2005
Clinical pharmacokinetics of trospium chlorideOxana Doroshyenko, Alexander Jetter, Karl P Odenthal, et al.
European Journal of Clinical Pharmacology|August 6, 2008
Professor Dr. Nina BakrachevaPetra A Thürmann, Emil Gatchev, Uwe Fuhr, et al.
European Journal of Clinical Pharmacology|August 14, 2015
Adverse events during placebo vs. no drug administration--results of a randomised interventional trial in 160 volunteersFrank Erbguth, Angelika Hamacher-Erbguth, Uwe Fuhr, et al.
Journal of Clinical Epidemiology|September 23, 2019
Reporting the details of consent procedures in clinical trialsRafael Dal Ré, Berge Solberg, Uwe Fuhr, et al.
Rapid Communications in Mass Spectrometry : RCM|June 25, 2004
Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometryDirk Kasel, Alexander Jetter, Steffi Harlfinger, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 8, 2022
Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groupsSimeon Rüdesheim, Dominik Selzer, Uwe Fuhr, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Biochemical Pharmacology|July 12, 2002
Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2Andreas Labedzki, Jeroen Buters, Wafaâ Jabrane, et al.
Rapid Communications in Mass Spectrometry : RCM|July 30, 2004
Quantification of mephenytoin and its metabolites 4'-hydroxymephenytoin and nirvanol in human urine using a simple sample processing methodTobias Klaassen, Dirk Kasel, Stefanie Harlfinger, et al.
Clinical Pharmacokinetics|August 14, 2008
Pharmacogenetics of oral anticoagulants: a basis for dose individualizationSimone Stehle, Julia Kirchheiner, Andreas Lazar, et al.
Toxicology Mechanisms and Methods|December 22, 2012
The role of human cytochrome P450 enzymes in metabolism of acrylamide in vitroDaria Kraus, Dennis Rokitta, Uwe Fuhr, et al.
Clinical Pharmacokinetics|June 22, 2005
Clinical pharmacokinetics of trospium chlorideOxana Doroshyenko, Alexander Jetter, Karl P Odenthal, et al.
European Journal of Clinical Pharmacology|August 6, 2008
Professor Dr. Nina BakrachevaPetra A Thürmann, Emil Gatchev, Uwe Fuhr, et al.
European Journal of Clinical Pharmacology|August 14, 2015
Adverse events during placebo vs. no drug administration--results of a randomised interventional trial in 160 volunteersFrank Erbguth, Angelika Hamacher-Erbguth, Uwe Fuhr, et al.
Journal of Clinical Epidemiology|September 23, 2019
Reporting the details of consent procedures in clinical trialsRafael Dal Ré, Berge Solberg, Uwe Fuhr, et al.
Rapid Communications in Mass Spectrometry : RCM|June 25, 2004
Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometryDirk Kasel, Alexander Jetter, Steffi Harlfinger, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 8, 2022
Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groupsSimeon Rüdesheim, Dominik Selzer, Uwe Fuhr, et al.
Pageof 14